Active smoking has a well-documented role in the etiology of inflammatory bowel disease (IBD), but the role of passive smoking has been unclear. This meta-analysis examined the relationship between prenatal smoke exposure and childhood passive smoke exposure and the development of IBD.
INTRODUCTION
The dramatic increase in the incidence of inflammatory bowel disease (IBD), especially Crohn's disease (CD), in developed countries in the second half of the 20th century highlights the important role that environmental factors play in the pathogenesis of IBD (1) . Cigarette smoking is one of the most well-documented environmental risk factors for IBD. Active smoking increases the risk of developing CD and is protective against the development of ulcerative colitis (UC) (2) .
In 1982, Harries et al. were the first to suggest that a relationship might also exist between passive smoke exposure and the development of IBD, although their study did not focus on children (3) . Since then, several case-control studies have addressed that possibility in regards to two specific categories of passive smoke exposure: prenatal exposure due to maternal smoking during pregnancy and passive smoke exposure during childhood (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . The conclusions drawn from these studies have been mixed. As both of these exposures are relatively common in the United States, with 9-34% of pregnant women smoking, and with 35% of children exposed to passive smoke at home, it is important to clarify any relationship that might exist between them and the development of IBD (17, 18) .
A meta-analysis is a method of pooling data from multiple studies in order to draw more definitive conclusions from a body of research. In 2000, the Meta-analysis of Observational Studies in Epidemiology Group published guidelines for the reporting of meta-analyses of observational studies. Using these guidelines as a framework, we performed a metaanalysis of the existing observational studies that explored the association between prenatal smoke exposure and/or passive smoke exposure during childhood and the subsequent development of IBD. Based on the well-established and divergent effects of active smoking on the risk for IBD, we hypothesized that passive smoke exposure in utero and during childhood would similarly, although perhaps to a lesser degree, increase the risk for CD development while decreasing the risk for the development of UC.
METHODS

Study Selection
We performed a search of the MEDLINE database for articles published between January 1950 and September 2007, using
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Ovid as a search engine and restricting our search to the English language publications involving humans. The following key words were used: ulcerative colitis, Crohn's disease, inflammatory bowel disease, maternal smoking, passive smoking, smoking, tobacco smoke, environmental risk factors, perinatal risk factors, fetal risk factors, and maternal perinatal behaviors. These key words were linked by the Boolean operators (and, or) to refine the search. We subsequently repeated this search using the identical search criteria in the EMBASE database. If a study could not be included/excluded based on the title and/or abstract, the full-text article was reviewed. Also, the reference lists of any studies meeting the inclusion criteria, as well as from pertinent review articles (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (19) (20) (21) (22) (23) , were reviewed manually to identify additional relevant publications.
Inclusion/Exclusion Criteria
The abstracts and full-text articles identified using the search algorithm were retrieved and evaluated for the presence of the following inclusion criteria:
r Observational studies that evaluate the association between prenatal and/or passive smoke exposure during childhood and the development of IBD later in life r Studies that include a control group (composed of community controls, hospital controls, clinic controls, or some combination thereof) r Studies that explicitly define prenatal/childhood passive smoke with the following:
• passive smoke exposure during childhood defined by age criteria or exposure in parental home.
• prenatal smoke exposure defined by maternal smoking during some part of pregnancy or maternal smoking at birth.
r Studies that are published as a full article in the English language.
One author (D.J.) performed the initial MEDLINE search, the results of which were scrutinized by two independent reviewers (D.J. and M.B.) to identify the studies for inclusion. One author (D.J.) performed the duplicate EMBASE search. Any discrepancies between the two reviewers were resolved by consultation with the senior author (J.L.).
Contact With Authors
When studies were identified with pertinent data not included in the publication (for example, if an estimate of effect was not included because the identified relationship was not statistically significant), attempts were made to contact the authors to procure the missing data. The authors of four of the included studies were contacted (6-9). The investigators from the studies published by Baron et al. in 2005 , Bernstein et al. in 2006 , and Feeney et al. in 2002 , supplied their data regarding prenatal and/or childhood passive smoke exposure and the development of CD and/or UC that had not been reported in the publication. The most adjusted estimates of effect provided by these investigators were utilized in our pooled analysis. When only the raw data were provided, we used these data to calculate the unadjusted estimates of effect for inclusion in our meta-analysis. We were unable to obtain the results for two of our subgroup analyses (subgroup of data limited to IBD diagnosed during childhood and subgroup of data limited to maternal source of passive smoke exposure) from the study performed by Eliakim et al. in 2000; however, this study was included in other analyses where data were available.
Data Abstraction
Data were abstracted by two independent investigators (D.J and M.O.) using a standardized data collection form. The discrepancies between the two abstractors were resolved by discussion, and if necessary, by re-evaluation by the senior author (J.L.). There was no blinding in the collection of data.
Rules for Choosing Among Several Estimates of Effect
Many of the studies meeting the inclusion criteria for this meta-analysis reported more than one estimate of effect in the results. For this reason, we developed an a priori criterion for choosing among the several estimates of effect. In all cases, the most adjusted estimate of effect was used in the pooling of data. If it was unclear which was most adjusted, the estimate of effect presented in the abstract was used. If separate estimates of effect were calculated for men and women as well as for both genders combined, the gender-combined estimate of effect was used. For childhood passive smoke exposure, only the estimates of effect based on exposure during childhood at home were used (the estimates of effect based on exposures at other locations were not used). If separate estimates of effect were calculated for individual sources of passive smoke exposure (mother, father, or other) as well as for overall passive smoke exposure, the most inclusive estimate of effect was used. If separate estimates of effect were calculated for separate control groups (community controls vs hospital controls), the estimate of effect based on comparison with the community controls was used as we felt this group of controls would be more representative of the general population. If estimates of effect were presented stratified by active smoking status, the estimate of effect calculated for nonsmokers was used. However, if an overall estimate of effect for all categories of active smoking status combined was presented, this estimate was used in the pooling of data. For prenatal smoke exposure, only the estimates of effect calculated for maternal smoking during pregnancy or maternal smoking at birth were used. The estimates of effect based on other sources of passive smoke exposure (paternal or other household member) during pregnancy or at birth were not used. Any dose-response data or estimates of effect calculated separately for groups with a longer period of time of smoke exposure were recorded separately, but were not included in the pooling of data.
Rating Study Quality
The studies were required to meet all three of the following predetermined criteria to be defined as "high quality."
1. Controls are community-based controls selected randomly by investigators, and not by cases. 2. Adequate definition of cases: CD/UC diagnosis confirmed by investigator/medical chart and not based solely on selfreport or some other subjective method of report. 3. Source of exposure data: information regarding classification of maternal smoking during pregnancy/childhood passive smoke exposure collected from parents or other older relative of study subject, or collected from medical charts/records from the time of exposure.
Statistical Analyses
A meta-analysis was performed according to the Metaanalysis of Observational Studies in Epidemiology guidelines (24) . The pooled odds ratios (OR) and its 95% confidence intervals (CI) were calculated using the DerSimonian and Laird method, which is based on a random effects model (25) . This model does not assume homogeneity among studies in terms of methodological or clinical characteristics, and is overall a more conservative approach than the fixed effects model. We tested for heterogeneity among studies using the χ 2 test as well as the I 2 test. The I 2 test describes the percentage of the variability in the estimates of effect that is due to heterogeneity rather than chance, with a value greater than 50% being considered having substantial heterogeneity (26, 27) . We also performed the Begg and Egger tests to evaluate for the presence of publication bias (28, 29) . All analyses were conducted using StataIC 10 (Stata Corp., College Station, TX). 
Subgroup Analyses
The subgroup analyses were performed to evaluate the robustness of the observed associations and to identify the sources of heterogeneity. Because so few studies met all three of our predetermined quality criteria, we expanded the inclusion criteria for this subgroup analysis in a second definition to include studies that met at least two of the three quality criteria. Because several previous studies from Israel have not found the typical relationship between active smoking and CD, one subgroup analysis excluded the studies performed in the Israeli populations (8, 30, 31) . Another analysis was limited to studies where all participants were diagnosed with IBD during childhood. Also, because it is well documented that the mother is the most important source for passive smoke exposure during childhood, we performed a subgroup analysis including only estimates of effect based on maternal smoking, and another analysis including only estimates not based exclusively on maternal smoking (32) (33) (34) (35) (36) . In addition, we performed a subgroup analysis based on the source of the case and control populations and stratified on whether the study was performed in U.S. populations or non-U.S. populations.
RESULTS
Search Results
Our search strategy in the MEDLINE database yielded a total of 534 studies, of which 70 were relevant to our general topic ( Fig. 1 ). Of those, 56 were excluded because they did not examine passive smoke exposure as an environmental risk factor for CD and/or UC. Finally, one of the remaining 14 studies was excluded because, although passive smoke exposure was studied as a risk factor, this exposure was not limited to that during childhood. The remaining 13 studies met all of the inclusion criteria (4-16). Our duplicate search of the EMBASE database yielded a total of 699 studies (including the 13 studies identified by our original search strategy and without any additional studies for inclusion). All of the studies utilized a case-control design. Some, but not all, studies limited the case populations to individuals diagnosed with CD or UC during childhood.
Childhood Passive Smoke Exposure and CD
Ten case-control studies regarding exposure to passive smoke during childhood included a total of 3,337 patients with CD and 3,955 controls (Tables 1 and 2 ). When the results from all of the studies were combined, passive smoke exposure was not associated with CD (pooled OR 1.10, 95% CI 0.92-1.30; test of heterogeneity P = 0.06, I 2 = 45.9%) ( Fig. 2A) . There was no evidence of publication bias in this overall analysis (Begg P value = 0.28, Egger P value = 0.50). The results of the subgroup analyses yielded OR's similar in magnitude and direction to the overall analysis (Table 3) . Only the subgroup analysis based on estimates of effect calculated for "mother" 
Childhood Passive Smoke Exposure and UC
Ten case-control studies regarding passive smoke exposure during childhood included a total of 2,155 patients with UC and 3,029 controls (Tables 1 and 2 ). When the results from all of the studies were combined, no association was observed between childhood passive smoke exposure and UC, with a pooled OR of 1.01 (95% CI 0.85-1.20; test of heterogeneity P = 0.24, I 2 = 22.1%), with no evidence of publication bias (Begg P value = 0.59, Egger P, value = 0.76) (Fig. 2B) . These results suggest that, in contrast to the inverse association between active smoking and UC development, there is no significant association between childhood passive smoke exposure and the development of UC. The results of all subgroup analyses yielded OR's similar in magnitude and direction to the overall analysis, with a 95% CI overlapping 1.0, while none of the analyses showed evidence of significant statistical heterogeneity (Table 4 ). Tables 5 and 6 ). The pooled OR for this analysis was 1.10 (95% CI 0.67-1.80), but with significant heterogeneity (test of heterogeneity P = 0.003, I 2 = 75.1%). There was no evidence of publication bias (Begg P value = 0.81, Egger P value = 0.33) (Fig. 3A) .
In the subgroup analyses, the results were similar in magnitude and direction to the overall analysis, and most showed evidence of significant heterogeneity among studies, suggesting that grouping of these studies for a pooled analysis may not be appropriate (Table 7) .
Prenatal Smoke Exposure and UC
Four case-control studies regarding exposure to maternal smoking during pregnancy included a total of 653 patients with UC and 1344,225 controls (1,343,619 were from a single study) (Tables 5 and 6 ). When the results from all of the studies were combined, the pooled OR was 1.11 (95% CI 0.63-1.97; test of heterogeneity P = 0.01, I 2 = 72.1%), suggesting that there is no significant overall association between prenatal smoke exposure and the development of UC, but again with significant heterogeneity among studies (Fig. 3B) . There was no evidence of publication bias (Begg P value = 1.0, Egger P value = 0.26). In the subgroup analyses, the analysis limited to studies performed with U.S. populations yielded a positive significant association (without evidence of significant heterogeneity among studies), while that limited to non-U.S. populations yielded a significant negative association (without evidence of significant heterogeneity among studies). In addition, the analysis limited to studies performed with outpatient/community case populations yielded a significant positive association (without evidence of significant heterogeneity among studies). None of the remaining subgroup analyses yielded a significant association (Table 8) .
DISCUSSION
The role of active smoking in the pathogenesis of IBD is well documented (3, 13, (37) (38) (39) (40) (41) (42) . A recent meta-analysis demonstrated significant positive associations with CD for current smoking (OR 1.76, 95% CI 1.40-2.22) and ever smoking (OR 1.61 95% CI 1.27-2.03), while current smoking had a protective effect on the development of UC (OR 0.58, 95% CI 0.45-0.75). As expected, former smoking increased the risk for UC (OR 1.79, 95% CI 1.37-2.34) (2).
We hypothesized that the roles of prenatal smoke exposure and childhood passive smoke exposure in the development of IBD would mirror that of active smoke exposure in promoting the development of CD while protecting against UC. Alternatively, prenatal and childhood passive smoke exposure may increase the risk for UC if the individuals exposed to smoke early in life, in effect, become "former smokers" when they are removed from the source of passive smoke. The overall pooled OR for the studies examining childhood passive smoke exposure suggests that there is no significant association between this exposure and the development of CD. For studies examining the relationship between childhood passive smoke exposure and the development of UC, the overall pooled OR convincingly demonstrated no significant association (pooled OR 1.01). The small number of studies and high degree of heterogeneity among studies precludes drawing any strong conclusions regarding prenatal smoke exposure and the risk of subsequently developing IBD. The studies included in this meta-analysis have individually drawn conflicting conclusions regarding the relationship between childhood passive smoke exposure and the development of IBD, particularly CD, which was confirmed by the finding of statistical heterogeneity in our overall analysis. There are several possible explanations for the heterogeneity in results: differences in study quality, lack of uniformity in the ethnicity of the study populations, differences in the methods of case and control identification and selection, differences in the control population characteristics (clinic controls vs community controls), differences in smoke exposure definitions, and variation in the latency period between the exposure to passive smoke in utero or during childhood and diagnosis of IBD (with some studies limited to diagnosis during childhood while others examining those diagnosed into their 60s and 70s).
When we performed the subgroup analyses, we were able to isolate the subgroups of studies based on the predetermined study characteristics that demonstrated less evidence of heterogeneity. The relationship between childhood passive smoke exposure and CD remained consistent in magnitude and direction across these analyses (all with OR >1.0), and in some cases, the relationship was strengthened. Of note, we observed a statistically significant positive association between childhood passive smoke exposure and CD when we limited our analysis to data regarding passive smoke exposure from a smoker mother (as opposed to analyses that included other household members as sources of passive smoke). However, the small number of studies and the pooled OR of only 1.31 preclude drawing any strong conclusions based on this subgroup analysis.
A dose-response relationship could explain our finding for passive smoke exposure (i.e., ORs greater than unity but smaller than those observed in Mahid et al.'s meta-analysis of active smoking and CD (2)). A dose-response relationship between smoke exposure and the risk for CD has been described for active smoking (13, 42) . Perhaps, passive smoke exposure during childhood is akin to a very low level of active smoke exposure, thus yielding a weaker positive association. Further support of this hypothesis is the limited data that have been published regarding a possible dose-response relationship between passive smoke exposure and the development of As noted previously, we found a statistically significant positive association between childhood passive smoke exposure and CD when we limited our analysis to data regarding passive smoke exposure from a smoker mother. Importantly, mothers are the primary source for childhood passive smoke exposure in the home (32-36, 43, 44) , and maternal smoking accounts for a greater percentage of the variation in urinary cotinine (a metabolite of nicotine) levels in children than all other sources combined (43) . As such, it is possible that this subgroup analysis represents an analysis based on the highest levels of passive smoke exposure. Our finding of a significant positive association between childhood passive smoke exposure and the development of CD in this subgroup provides further support to the dose-response relationship. However, as already described, this result must be interpreted with caution.
We performed similar subgroup analyses for the data regarding childhood passive smoke exposure and the development of UC. All of the analyses demonstrated an effect similar in direction to the overall analysis, with a 95% CI overlapping 1.0. Neither the overall pooled analysis nor any of the subgroups showed significant heterogeneity. Thus, it is unlikely that childhood passive smoke exposure significantly alters the risk of the development of UC. The dose-response relationship is again a possible explanation for the failure of this meta-analysis to show a protective effect of childhood passive smoke exposure on UC, as a negative dose-response relationship has been documented for active smoking (42, 45) . It is possible that the level of childhood passive smoke exposure does not reach a threshold level that is required for the protective effect that has been well documented in active smokers.
For prenatal smoke exposure, the overall analyses for both CD and UC revealed no significant association, but with significant heterogeneity among studies for both diseases. This degree of heterogeneity suggests to us that this small group of studies regarding prenatal smoke exposure and the development of IBD cannot be combined to come up with a definitive conclusion. Studies with larger numbers of participants and a more detailed quantification of the amount of maternal smoking during pregnancy are needed before definitive conclusions can be drawn.
When studies regarding prenatal smoke exposure were divided into two groups: one that included a U.S. study population and the other group including all studies with non-U.S. populations, the results were remarkably different. For UC, the division of the studies based on this characteristic led to the observation of a statistically significant positive association between prenatal smoke exposure and the development of UC for U.S. populations and a statistically significant negative association for non-U.S. populations. Furthermore, the subgroup analysis based on studies with outpatient/community case populations led to the observation of a small, but statistically significant, positive association. We attribute these surprising results to chance, given the small number of studies available for the meta-analysis.
The limitations of this meta-analysis include the relatively small number of studies available for pooling, especially in the case of prenatal smoke exposure. Also, our pooled analyses were hindered by significant heterogeneity among studies, both in study design and in study population characteristics. In some cases, we were able to address this heterogeneity by performing the subgroup analyses, but in other cases, this significant heterogeneity remained even in the subgroup analyses, indicating that pooling may have been inappropriate for those studies. In addition, all of the studies were retrospective, and therefore, possibly subject to recall bias. Finally, none of the studies were limited to offspring of parents with IBD, a population that may be at a particularly high risk to develop IBD. A study examining the risk of IBD associated with passive smoke exposure in this already at-risk population may be more likely to find an association. In conclusion, our findings do not support a strong association between childhood passive smoke exposure and CD. In contrast to the inverse association that has been documented to exist between active smoking and UC, we found no association between childhood passive smoke exposure and UC. It is possible that this can be explained by childhood passive smoke exposure not generating sufficient levels of smoke exposure to execute protective effects against UC. Likewise, we found no evidence of a relationship between prenatal smoke exposure and either CD or UC. However, due to the small number of studies addressing this question and the significant heterogeneity among studies, the effect of prenatal smoke exposure on the risk of IBD remains unclear. In the future, it would be informative to perform studies that use urinary cotinine levels to quantify levels of passive smoke exposure to further examine these relationships and conduct studies limited to offspring of parents with IBD.
